SCHEMBL3770876

SCHEMBL3770876

CCC=CCCCCOc1cccc(CN)c1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.38
TDP1 Q9NUW8 1/20 0.35
LPAR2 Q9HBW0 3/20 0.34
LPAR3 Q9UBY5 3/20 0.34
MAPT P10636 3/20 0.34
LPAR1 Q92633 1/20 0.34
MEN1 O00255 1/20 0.34
NR1I2 O75469 1/20 0.34
LMNA P02545 1/20 0.34
CHRM2 P08172 1/20 0.34
CYP3A4 P08684 1/20 0.34
ADRA2A P08913 1/20 0.34
OPRK1 P41145 1/20 0.34
HTR2B P41595 1/20 0.34
SLC6A3 Q01959 1/20 0.34
KMT2A Q03164 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3771934 0.96 L3MBTL1 (0.39) L3MBTL1TDP1MAPTMEN1NR1I2
SCHEMBL3772715 0.92 RPS6KA1 (0.34) L3MBTL1TDP1MAPTLMNACHRM2
SCHEMBL3766281 0.87 L3MBTL1 (0.36) L3MBTL1TDP1MAPTLMNACYP3A4
SCHEMBL3766396 0.87 L3MBTL1 (0.39) L3MBTL1TDP1MAPTCYP1A2CYP2C9
SCHEMBL3764583 0.86 CYP1A2 (0.40) L3MBTL1MAPTMEN1NR1I2LMNA
SCHEMBL3770673 0.86 L3MBTL1 (0.35) L3MBTL1TDP1MAPTMEN1NR1I2
SCHEMBL3770868 0.83 L3MBTL1 (0.36) L3MBTL1TDP1MAPTCYP1A2CYP2C9
SCHEMBL3766158 0.83 CYP1A2 (0.35) L3MBTL1TDP1MAPTHTR2BCYP1A2
SCHEMBL3768083 0.82 TAAR1 (0.38) L3MBTL1MAPTRPS6KA1
SCHEMBL3771175 0.82 CYSLTR2 (0.42) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME SUMITOMO CHIEMCAL COMPANY LIMITED (JP) 2010-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME ATL3, NAT1, C5 L3MBTL1 40/4885TDP1 4310/4885LPAR2 417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.